Quality of Life in Patients With Congenital Afibrinogenemia

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

June 30, 2020

Conditions
Afibrinogenemia, Congenital
Interventions
OTHER

Questionnaire quality of life

Trial Locations (28)

11040

Cohen Children's Medical Center, New Hyde Park

92868

Children's Hospital of Orange Count, Orange

Unknown

Béni Messous, Algiers

University of Calgary, Calgary

Cairo University Pediatric Hospital, Cairo

Chru Lille, Lille

Universitats Kilinikum Frankfurt, Frankfurt

Dr von Haumer Children's Hospital, Munich

St John Medical College Hospital, Bangalore

All India Institute of Medical Sciences, New Delhi

Sapienza Università di Roma, Roma

University School of Medicine, Hamamatsu

Kuwait University, Kuwait City

Hotel Dieu-de-France, Beirut

St George Hospital, Beirut

Hopital d'Enfants de Rabat, Rabat

Radboud University Medical Centre, Nijmegen

National Institute Of Blood Disease and Bone Marrow Transplantation, Karachi

Institute of Hematology and Transfusion Medicine, Warsaw

University Clinical Center, Belgrade

National Centre of Hemostasis and Thrombosis, Martin

Hospital Universitari i Politecnic La Fe, Valencia

Inselspital, Bern

University Hospitals of Geneva, Geneva

Hopital d'Enfants Bechir Hamza, Tunis

Uludag University, Bursa

Cerrahpasa Faculty of Medicine, Istanbul

Erciyes University, Kayseri

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT03484065 - Quality of Life in Patients With Congenital Afibrinogenemia | Biotech Hunter | Biotech Hunter